NSN 6505-01-049-6735 of Clonazepam Tablets Usp - Parts Details
| Alternative NSN: 6505010496735 |
| Item Name: Clonazepam Tablets Usp |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 010496735 |
| NCB Code: USA (01) |
| Manufacturers: Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Actavis Pharma Inc , Teva Pharmaceuticals Usa Inc , Hoffmannla Roche Inc , Roche Laboratories Inc |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC00591-0746-01, NDC00378-1910-01, NDC00228-3003-11, NDC00093-0832-01, NDC00004-0068-45 under NSN 6505-01-049-6735 of Clonazepam Tablets Usp manufactured by Danbury Pharmacal Inc, Mylan Pharmaceuticals Inc, Actavis Pharma Inc, Teva Pharmaceuticals Usa Inc, Hoffmannla Roche Inc.
Federal Supply Class of NSN 6505-01-049-6735 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-049-6735, 6505010496735
-
Part No Manufacturer Item Name QTY RFQ NDC00591-0746-01 Danbury Pharmacal Inc clonazepam tablets usp Avl RFQ NDC00378-1910-01 Mylan Pharmaceuticals Inc clonazepam tablets usp Avl RFQ NDC00228-3003-11 Actavis Pharma Inc clonazepam tablets usp Avl RFQ NDC00093-0832-01 Teva Pharmaceuticals Usa Inc clonazepam tablets usp Avl RFQ NDC00004-0068-45 Hoffmannla Roche Inc clonazepam tablets usp Avl RFQ NDC00004-0068-01 Roche Laboratories Inc clonazepam tablets usp Avl RFQ 71816 Hoffmannla Roche Inc clonazepam tablets usp Avl RFQ
Characteristics Data of NSN 6505010496735MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT CQCT PRIMARY CONTAINER TYPE BOTTLE CRLK PRIMARY CONTAINER CONTENT QUANTITY 100.000 TABLETS CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY CLONAZEPAM TABLETS USP 0.5 MG 100S BT FEAT SPECIAL FEATURES CLASS 4 MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.500 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 0.5 MG 100S BT |
| FEAT | SPECIAL FEATURES | CLASS 4 |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |